Diagnostic performance of metagenomic next-generation sequencing for the detection of pathogens in cerebrospinal fluid in pediatric patients with central nervous system infection: a systematic review and meta-analysis
- PMID: 38238719
- PMCID: PMC10797782
- DOI: 10.1186/s12879-024-09010-y
Diagnostic performance of metagenomic next-generation sequencing for the detection of pathogens in cerebrospinal fluid in pediatric patients with central nervous system infection: a systematic review and meta-analysis
Abstract
Background: Detecting pathogens in pediatric central nervous system infection (CNSI) is still a major challenge in medicine. In addition to conventional diagnostic patterns, metagenomic next-generation sequencing (mNGS) shows great potential in pathogen detection. Therefore, we systematically evaluated the diagnostic performance of mNGS in cerebrospinal fluid (CSF) in pediatric patients with CNSI.
Methods: Related literature was searched in the Web of Science, PubMed, Embase, and Cochrane Library. We screened the literature and extracted the data according to the selection criteria. The quality of included studies was assessed by the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool and the certainty of the evidence was measured by the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) score system. Then, the pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odd's ratio (DOR), and area under the curve (AUC) of the summary receiver operating characteristic curve (sROC) were estimated in Stata Software and MetaDisc. Subgroup analyses were performed to investigate the potential factors that influence the diagnostic performance.
Results: A total of 10 studies were included in the meta-analysis. The combined sensitivity was 0.68 (95% confidence interval [CI]: 0.59 to 0.76, I2 = 66.77%, p < 0.001), and the combined specificity was 0.89 (95% CI: 0.80 to 0.95, I2 = 83.37%, p < 0.001). The AUC of sROC was 0.85 (95% CI, 0.81 to 0.87). The quality level of evidence elevated by the GRADE score system was low.
Conclusions: Current evidence shows that mNGS presents a good diagnostic performance in pediatric CNSI. Due to the limited quality and quantity of the included studies, more high-quality studies are needed to verify the above conclusion.
Keywords: Central nervous system infection; Diagnostic performance; Meta-analysis; Metagenomic next-generation sequencing; Pediatric infection.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Exploring the clinical and diagnostic value of metagenomic next-generation sequencing for urinary tract infection: a systematic review and meta-analysis.BMC Infect Dis. 2024 Sep 18;24(1):1000. doi: 10.1186/s12879-024-09914-9. BMC Infect Dis. 2024. PMID: 39294577 Free PMC article.
-
The clinical utility of metagenomic next-generation sequencing for the diagnosis of central nervous system infectious diseases.Neurol Res. 2023 Oct;45(10):919-925. doi: 10.1080/01616412.2023.2247299. Epub 2023 Aug 24. Neurol Res. 2023. PMID: 37615407
-
An Investigation into Diagnostic Strategies for Central Nervous System Infections Through the Integration of Metagenomic Next-Generation Sequencing and Conventional Diagnostic Methods.Infect Drug Resist. 2024 Nov 5;17:4865-4873. doi: 10.2147/IDR.S483985. eCollection 2024. Infect Drug Resist. 2024. PMID: 39524979 Free PMC article.
-
Metagenomics next-generation sequencing for the diagnosis of central nervous system infection: A systematic review and meta-analysis.Front Neurol. 2022 Sep 20;13:989280. doi: 10.3389/fneur.2022.989280. eCollection 2022. Front Neurol. 2022. PMID: 36203993 Free PMC article.
-
Diagnostic performance of metagenomic next-generation sequencing for Pneumocystis jirovecii pneumonia.BMC Infect Dis. 2023 Jul 10;23(1):455. doi: 10.1186/s12879-023-08440-4. BMC Infect Dis. 2023. PMID: 37430211 Free PMC article. Review.
Cited by
-
From Tradition to Innovation: Diverse Molecular Techniques in the Fight Against Infectious Diseases.Diagnostics (Basel). 2024 Dec 21;14(24):2876. doi: 10.3390/diagnostics14242876. Diagnostics (Basel). 2024. PMID: 39767237 Free PMC article. Review.
-
Exploring the clinical and diagnostic value of metagenomic next-generation sequencing for urinary tract infection: a systematic review and meta-analysis.BMC Infect Dis. 2024 Sep 18;24(1):1000. doi: 10.1186/s12879-024-09914-9. BMC Infect Dis. 2024. PMID: 39294577 Free PMC article.
-
A retrospective analysis comparing metagenomic next-generation sequencing with conventional microbiology testing for the identification of pathogens in patients with severe infections.Front Cell Infect Microbiol. 2025 Apr 8;15:1530486. doi: 10.3389/fcimb.2025.1530486. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40264936 Free PMC article.
-
Metagenomic next-generation sequencing (mNGS) versus tissue culture technique (TCT) in diagnosis of spinal infection: a systematic review and meta-analysis.Sci Rep. 2025 Jul 1;15(1):20926. doi: 10.1038/s41598-025-06759-3. Sci Rep. 2025. PMID: 40596444 Free PMC article.
-
Metagenomic detection of central nervous system infections missedby conventional testing.JCI Insight. 2025 May 20;10(13):e189295. doi: 10.1172/jci.insight.189295. eCollection 2025 Jul 8. JCI Insight. 2025. PMID: 40392601 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources